Author:
Casado-Díaz Antonio,Santiago-Mora Raquel,Dorado Gabriel,Quesada-Gómez José Manuel
Reference40 articles.
1. Bisphosphonates: the first 40 years;Russell;Bone,2011
2. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy;Russell;Osteoporos Int,2008
3. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro;Fisher;Proc Natl Acad Sci USA,1999
4. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway;Fisher;Endocrinology,2000
5. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases;Dunford;J Bone Miner Res,2006
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献